Dr Shah, Senior Fellow of Vivo Capital, was formerly a Managing Partner at the healthcare investment firm. Dr Shah is also the founder and Executive Chair of Semnur Pharmaceuticals (acquired by Scilex Pharmaceuticals), a specialty pharmaceutical company. Dr Shah previously served as a board member of Soleno Therapeutics, Crinetics Pharmaceuticals, Aadi Bioscience and Homology Medicines. He currently serves as a member of the board of directors of several private companies in the biopharmaceutical and biotechnology industries. Dr Shah received his PhD in industrial pharmacy from St John’s University and a Master’s Degree in Pharmacy from LM College of Pharmacy in Gujarat, India.